RECATICIMAB
UNII 20IE6M67UX

Substance Identification & Data

This profile provides standardized clinical and technical data for Recaticimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 20IE6M67UX.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2361290-85-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

20IE6M67UX

CAS Registry Number

2361290-85-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

RECATICIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C175849

National Cancer Institute reference terminology for clinical and research data.

INN ID

11502

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Recaticimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

RECATICIMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1 (256-TYROSINE,258-THREONINE,260-GLUTAMIC ACID), ANTI-(NEURAL APOPTOSIS-REGULATED PROTEINASE 1) (HUMAN-MUS MUSCULUS MONOCLONAL HRP00130 .GAMMA.1-CHAIN), DISULFIDE WITH (3-VALINE,5-SERINE,49-SERINE,66-ASPARTIC ACID) HUMAN-MUS MUSCULUS MONOCLONAL HRP00130 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1 (256-TYROSINE,258-THREONINE,260-GLUTAMIC ACID), ANTI-(PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9) (HUMAN-MUS MUSCULUS MONOCLONAL HRP00130 .GAMMA.1-CHAIN), DISULFIDE WITH (3-VALINE,5-SERINE,49-SERINE,66-ASPARTIC ACID) HUMAN-MUS MUSCULUS MONOCLONAL HRP00130 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENSPCSK9 (PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9, NEURAL APOPTOSIS-REGULATED CONVERTASE 1, NARC1, NARC-1, PROPROTEINE CONVERTASE 9, PC9)), MONOCLONAL ANTIBODY (RECATICIMAB)

RECATICIMAB [INN]

SHR 1209 [WHO-DD]